<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36902041</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4610</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24054610</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is characterized by the progressive, irreversible loss of upper and lower motor neurons (UMNs, LMNs). MN axonal dysfunctions are emerging as relevant pathogenic events since the early ALS stages. However, the exact molecular mechanisms leading to MN axon degeneration in ALS still need to be clarified. MicroRNA (miRNA) dysregulation plays a critical role in the pathogenesis of neuromuscular diseases. These molecules represent promising biomarkers for these conditions since their expression in body fluids consistently reflects distinct pathophysiological states. Mir-146a has been reported to modulate the expression of the NFL gene, encoding the light chain of the neurofilament (NFL) protein, a recognized biomarker for ALS. Here, we analyzed miR-146a and <i>Nfl</i> expression in the sciatic nerve of G93A-SOD1 ALS mice during disease progression. The miRNA was also analyzed in the serum of affected mice and human patients, the last stratified relying on the predominant UMN or LMN clinical signs. We revealed a significant miR-146a increase and <i>Nfl</i> expression decrease in G93A-SOD1 peripheral nerve. In the serum of both ALS mice and human patients, the miRNA levels were reduced, discriminating UMN-predominant patients from the LMN ones. Our findings suggest a miR-146a contribution to peripheral axon impairment and its potential role as a diagnostic and prognostic biomarker for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giagnorio</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5226-1593</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malacarne</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9208-021X</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ph.D. Program in Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavalcante</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1497-1524</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandiffio</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1853-2956</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cattaneo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pensato</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gellera</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riva</LastName><ForeName>Nilo</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0513-9517</Identifier><AffiliationInfo><Affiliation>Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quattrini</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8226-8320</Identifier><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalla Bella</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauria</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Vanvitelli 32, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantegazza</LastName><ForeName>Renato</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9810-5737</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8823-6821</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcuzzo</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6893-6372</Identifier><AffiliationInfo><Affiliation>Neurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ID 1157625</GrantID><Agency>Fondazione Regionale per la Ricerca Biomedica POR FESR 2014-2020 under INTERSLA project</Agency><Country/></Grant><Grant><GrantID>RRC</GrantID><Agency>The Italian Ministry of Health (RRC)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C542542">MIRN146 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C044882">neurofilament protein L</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C534190">Mirn146 microRNA, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="Y">Nerve Degeneration</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010525" MajorTopicYN="N">Peripheral Nerves</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="N">Neurofilament Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">axon degeneration</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">microRNA-146a</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36902041</ArticleId><ArticleId IdType="pmc">PMC10002507</ArticleId><ArticleId IdType="doi">10.3390/ijms24054610</ArticleId><ArticleId IdType="pii">ijms24054610</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., Van Den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G., Eurals Consortium Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S., Khurana S., Vats A., Sahu B., Ganguly N.K., Chakraborti P., Gourie-Devi M., Taneja V. Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol. Neurobiol. 2022;59:1502&#x2013;1527. doi: 10.1007/s12035-021-02658-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02658-6</ArticleId><ArticleId IdType="pubmed">34997540</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N., Chaabane L., Peviani M., Ungaro D., Domi T., Dina G., Bianchi F., Spano G., Cerri F., Podini P., et al. Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2014;73:658&#x2013;670. doi: 10.1097/NEN.0000000000000081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000081</ArticleId><ArticleId IdType="pubmed">24918640</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Bonanno S., Figini M., Scotti A., Zucca I., Minati L., Riva N., Domi T., Fossaghi A., Quattrini A., et al. A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2017;293:43&#x2013;52. doi: 10.1016/j.expneurol.2017.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.03.018</ArticleId><ArticleId IdType="pubmed">28351750</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., Verderio M., Mariani A., de Paola M., Riva N., Dina G., Panini N., Erba E., Quattrini A., et al. Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice. Mol. Neurodegener. 2018;13:42. doi: 10.1186/s13024-018-0271-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0271-7</ArticleId><ArticleId IdType="pmc">PMC6085701</ArticleId><ArticleId IdType="pubmed">30092791</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Chen L., Zhang S., He J., Fan D. Early axonal dysfunction of the peripheral nervous system influences disease progression of ALS: Evidence from clinical neuroelectrophysiology. Front. Neurol. 2021;12:574919. doi: 10.3389/fneur.2021.574919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.574919</ArticleId><ArticleId IdType="pmc">PMC7905229</ArticleId><ArticleId IdType="pubmed">33643181</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial amyotrophic lateral sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Brown R.H., Jr. Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect. Med. 2018;8:a024125. doi: 10.1101/cshperspect.a024125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaepfel B.L., Rothstein J.D. RNA Is a double-Edged sword in ALS pathogenesis. Front. Cell. Neurosci. 2021;15:708181. doi: 10.3389/fncel.2021.708181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.708181</ArticleId><ArticleId IdType="pmc">PMC8326408</ArticleId><ArticleId IdType="pubmed">34349625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkar N., Boehringer A., Bowser R. Use of biomarkers in ALS drug development and clinical trials. Brain Res. 2015;1607:94&#x2013;107. doi: 10.1016/j.brainres.2014.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.10.031</ArticleId><ArticleId IdType="pmc">PMC4809521</ArticleId><ArticleId IdType="pubmed">25452025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., McDermott C.J., Hardiman O., Shefner J.M., Al-Chalabi A., Huynh W., Cudkowicz M., Talman P., et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2021;17:104&#x2013;118. doi: 10.1038/s41582-020-00434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Gille B., De Schaepdryver M., Goossens J., Dedeene L., De Vocht J., Oldoni E., Goris A., Van Den Bosch L., Depreitere B., Claeys K.G., et al. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. Neuropathol. Appl. Neurobiol. 2019;45:291&#x2013;304. doi: 10.1111/nan.12511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12511</ArticleId><ArticleId IdType="pubmed">29908069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Ji T., Wu C., Zhang S., Tang L., Zhang N., Liu X., Fan D. Serum neurofilament light chain levels may be a marker of lower motor neuron damage in amyotrophic lateral sclerosis. Front. Neurol. 2022;13:833507. doi: 10.3389/fneur.2022.833507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.833507</ArticleId><ArticleId IdType="pmc">PMC8905596</ArticleId><ArticleId IdType="pubmed">35280276</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Otto M., Silani V. Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia. Front. Neurosci. 2021;15:679199. doi: 10.3389/fnins.2021.679199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.679199</ArticleId><ArticleId IdType="pmc">PMC8255624</ArticleId><ArticleId IdType="pubmed">34234641</ArticleId></ArticleIdList></Reference><Reference><Citation>Behzadi A., Pujol-Calder&#xf3;n F., Tjust A.E., Wuolikainen A., H&#xf6;glund K., Forsberg K., Portelius E., Blennow K., Zetterberg H., Andersen P.M. Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics. Sci. Rep. 2021;11:22128. doi: 10.1038/s41598-021-01499-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01499-6</ArticleId><ArticleId IdType="pmc">PMC8585882</ArticleId><ArticleId IdType="pubmed">34764380</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2019;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Laneve P., Tollis P., Caffarelli E. RNA deregulation in amyotrophic lateral sclerosis: The Noncoding Perspective. Int. J. Mol. Sci. 2021;22:10285. doi: 10.3390/ijms221910285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910285</ArticleId><ArticleId IdType="pmc">PMC8508793</ArticleId><ArticleId IdType="pubmed">34638636</ArticleId></ArticleIdList></Reference><Reference><Citation>Saliminejad K., Khorram Khorshid H.R., Soleymani Fard S., Ghaffari S.H. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J. Cell. Physiol. 2019;234:5451&#x2013;5465. doi: 10.1002/jcp.27486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27486</ArticleId><ArticleId IdType="pubmed">30471116</ArticleId></ArticleIdList></Reference><Reference><Citation>Im H.I., Kenny P.J. MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 2012;35:325&#x2013;334. doi: 10.1016/j.tins.2012.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2012.01.004</ArticleId><ArticleId IdType="pmc">PMC3565236</ArticleId><ArticleId IdType="pubmed">22436491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajman M., Schratt G. MicroRNAs in neural development: From master regulators to fine-tuners. Development. 2017;144:2310&#x2013;2322. doi: 10.1242/dev.144337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.144337</ArticleId><ArticleId IdType="pubmed">28676566</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Kapetis D., Mantegazza R., Baggi F., Bonanno S., Barzago C., Cavalcante P., Kerlero de Rosbo N., Bernasconi P. Altered miRNA expression is associated with neuronal fate in G93A-SOD1 ependymal stem progenitor cells. Exp. Neurol. 2014;253:91&#x2013;101. doi: 10.1016/j.expneurol.2013.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.12.007</ArticleId><ArticleId IdType="pubmed">24365539</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Bonanno S., Kapetis D., Barzago C., Cavalcante P., D'Alessandro S., Mantegazza R., Bernasconi P. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage. Mol. Brain. 2015;8:5. doi: 10.1186/s13041-015-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0095-0</ArticleId><ArticleId IdType="pmc">PMC4318136</ArticleId><ArticleId IdType="pubmed">25626686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanno S., Marcuzzo S., Malacarne C., Giagnorio E., Masson R., Zanin R., Arnoldi M.T., Andreetta F., Simoncini O., Venerando A., et al. Circulating MyomiRs as potential biomarkers to monitor response to nusinersen in pediatric SMA patients. Biomedicines. 2020;8:21. doi: 10.3390/biomedicines8020021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8020021</ArticleId><ArticleId IdType="pmc">PMC7168147</ArticleId><ArticleId IdType="pubmed">31991852</ArticleId></ArticleIdList></Reference><Reference><Citation>Giagnorio E., Malacarne C., Mantegazza R., Bonanno S., Marcuzzo S. MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis. J. Cell Sci. 2021;134:jcs258349. doi: 10.1242/jcs.258349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.258349</ArticleId><ArticleId IdType="pubmed">34137441</ArticleId></ArticleIdList></Reference><Reference><Citation>Malacarne C., Galbiati M., Giagnorio E., Cavalcante P., Salerno F., Andreetta F., Cagnoli C., Taiana M., Nizzardo M., Corti S., et al. Dysregulation of muscle-specific microRNAs as common pathogenic feature associated with muscle atrophy in ALS, SMA and SBMA: Evidence from animal models and human patients. Int. J. Mol. Sci. 2021;22:5673. doi: 10.3390/ijms22115673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115673</ArticleId><ArticleId IdType="pmc">PMC8198536</ArticleId><ArticleId IdType="pubmed">34073630</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in amyotrophic lateral sclerosis: A role in the regulation of NFL mRNA levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V., Merico A., Angelini C. Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration. J. Neurol. Sci. 2017;380:58&#x2013;63. doi: 10.1016/j.jns.2017.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.008</ArticleId><ArticleId IdType="pmc">PMC5598142</ArticleId><ArticleId IdType="pubmed">28870590</ArticleId></ArticleIdList></Reference><Reference><Citation>Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA. 2006;103:12481&#x2013;12486. doi: 10.1073/pnas.0605298103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605298103</ArticleId><ArticleId IdType="pmc">PMC1567904</ArticleId><ArticleId IdType="pubmed">16885212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Sequeira C., Likhite S., Dennys C.N., Kolb S.J., Shaw P.J., Vaz A.R., Kaspar B.K., Meyer K., Brites D. Neurotoxic astrocytes directly converted from sporadic and familial ALS patient fibroblasts reveal signature diversities and miR-146a theragnostic potential in specific subtypes. Cells. 2022;11:1186. doi: 10.3390/cells11071186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071186</ArticleId><ArticleId IdType="pmc">PMC8997588</ArticleId><ArticleId IdType="pubmed">35406750</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry D.M., Millecamps S., Julien J.P., Garcia M.L. New movements in neurofilament transport, turnover and disease. Exp. Cell Res. 2007;313:2110&#x2013;2120. doi: 10.1016/j.yexcr.2007.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2007.03.011</ArticleId><ArticleId IdType="pubmed">17451679</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Qin X., Chang X., Wang H., Guo J., Zhang W. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J. Cell. Mol. Med. 2022;26:583&#x2013;587. doi: 10.1111/jcmm.17100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17100</ArticleId><ArticleId IdType="pmc">PMC8743649</ArticleId><ArticleId IdType="pubmed">34866307</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N., Akiyama T., Warita H., Aoki M. Omics approach to axonal dysfunction of motor neurons in amyotrophic lateral sclerosis (ALS) Front Neurosci. 2020;14:194. doi: 10.3389/fnins.2020.00194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00194</ArticleId><ArticleId IdType="pmc">PMC7109447</ArticleId><ArticleId IdType="pubmed">32269505</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Wang L., Chopp M., Zhang Y., Szalad A., Zhang Z.G. MicroRNA 146a locally mediates distal axonal growth of dorsal root ganglia neurons under high glucose and sildenafil conditions. Neuroscience. 2016;329:43&#x2013;53. doi: 10.1016/j.neuroscience.2016.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.05.005</ArticleId><ArticleId IdType="pmc">PMC4905785</ArticleId><ArticleId IdType="pubmed">27167084</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., Liang C., Ou M., Zou T., Sun F., Zhou H., Cui L. MicroRNA-146a Is a Wide-Reaching Neuroinflammatory regulator and potential treatment target in neurological diseases. Front. Mol. Neurosci. 2020;13:90. doi: 10.3389/fnmol.2020.00090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00090</ArticleId><ArticleId IdType="pmc">PMC7291868</ArticleId><ArticleId IdType="pubmed">32581706</ArticleId></ArticleIdList></Reference><Reference><Citation>Yichen L., Lee B.H., Yip W., Chou P., Yip B.S. Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders. Curr. Pharm. Des. 2019;25:4560&#x2013;4569 . doi: 10.2174/1381612825666191210154535.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666191210154535</ArticleId><ArticleId IdType="pubmed">31820696</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.-J., Nguyen P.N.N., Choo K.B., Sugii S., Wee K., Cheong S.K., Kamarul T. Frequent Co-Expression of miRNA-5p and -3p Species and Cross-Targeting in Induced Pluripotent Stem Cells. Int. J. Med Sci. 2014;11:824&#x2013;833. doi: 10.7150/ijms.8358.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.8358</ArticleId><ArticleId IdType="pmc">PMC4057479</ArticleId><ArticleId IdType="pubmed">24936146</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurikova O.Y., Aisina D.E., Niyazova R.E., Atambayeva S.A., Labeit S., Ivashchenko A.T. The Interaction of miRNA-5p and miRNA-3p with the mRNAs of Orthologous Genes. Bioinformatics. 2019;53:692&#x2013;704. doi: 10.1134/S0026893319040174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0026893319040174</ArticleId><ArticleId IdType="pubmed">31397443</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A., Nixon R.A. Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front. Neurosci. 2021;15:689938. doi: 10.3389/fnins.2021.689938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.689938</ArticleId><ArticleId IdType="pmc">PMC8503617</ArticleId><ArticleId IdType="pubmed">34646114</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Martone J., Lepore E., Casola I., Petrucci A., Inghilleri M., Morlando M., Colantoni A., Scicchitano B.M., Calvo A., et al. A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients. Cell Death Discov. 2021;7:4. doi: 10.1038/s41420-020-00397-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00397-6</ArticleId><ArticleId IdType="pmc">PMC7801652</ArticleId><ArticleId IdType="pubmed">33431881</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Cui X., Crossman D.K., Hao J., Kazamel M., Kwon Y., King P.H. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis. Neurobiol. Dis. 2018;114:85&#x2013;94. doi: 10.1016/j.nbd.2018.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.02.009</ArticleId><ArticleId IdType="pmc">PMC5891369</ArticleId><ArticleId IdType="pubmed">29486297</ArticleId></ArticleIdList></Reference><Reference><Citation>Condrat C.E., Thompson D.C., Barbu M.G., Bugnar O.L., Boboc A., Cretoiu D., Suciu N., Cretoiu S.M., Voinea S.C. miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cells. 2020;9:276. doi: 10.3390/cells9020276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020276</ArticleId><ArticleId IdType="pmc">PMC7072450</ArticleId><ArticleId IdType="pubmed">31979244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C., Marzocchi C., Battistini S. MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells. 2018;7:219. doi: 10.3390/cells7110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110219</ArticleId><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Zucca I., Mastropietro A., de Rosbo N.K., Cavalcante P., Tartari S., Bonanno S., Preite L., Mantegazza R., Bernasconi P. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: A longitudinal MRI study. Exp. Neurol. 2011;231:30&#x2013;37. doi: 10.1016/j.expneurol.2011.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.05.007</ArticleId><ArticleId IdType="pubmed">21620832</ArticleId></ArticleIdList></Reference><Reference><Citation>Nango H., Kosuge Y., Sato M., Shibukawa Y., Aono Y., Saigusa T., Ito Y., Ishige K. Highly Efficient Conversion of Motor Neuron-Like NSC-34 Cells into Functional Motor Neurons by Prostaglandin E2. Cells. 2020;9:1741. doi: 10.3390/cells9071741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071741</ArticleId><ArticleId IdType="pmc">PMC7409148</ArticleId><ArticleId IdType="pubmed">32708195</ArticleId></ArticleIdList></Reference><Reference><Citation>Genevini P., Colombo M.N., Venditti R., Marcuzzo S., Colombo S.F., Bernasconi P., De Matteis M.A., Borgese N., Navone F. VAPB depletion alters neuritogenesis and phosphoinositide balance in motoneuron-like cells: Relevance to VAPB-linked amyotrophic lateral sclerosis. J. Cell Sci. 2019;132:jcs220061. doi: 10.1242/jcs.220061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.220061</ArticleId><ArticleId IdType="pubmed">30745341</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>